semaglutide pfizer The race for the next Ozempic is on Companies seek a second obesity

Menstrual changes are particularly common, especially at higher doses

Ongoing long-term studies and cancer-specific registries are needed to provide more definitive answers about safety in breast cancer survivors specifically

However, scientific advancements have led to new treatments like GLP-1 drugs, which can help reduce visceral fat and improve overall metabolic health

Ozempic is a once-weekly subcutaneous injection used primarily for type 2 diabetes mellitus

Home Bedding Market Size The global GLP-1 receptor agonist market reached a value of nearly $65,865.6 million in 2025, having grown at a compound annual growth rate (CAGR) of 37.0% since 2020